Genetically Modified Viruses Vaccines by Design

Author: Stephenson J.R.

Source: Current Pharmaceutical Biotechnology, Volume 2, Number 1, March 2001 , pp. 47-76(30)

Publisher: Bentham Science Publishers

Abstract:

Vaccination has been one of the most successful and cost-effective healthinterventions ever employed. One disease (smallpox) has been eradicated, another(poliomyelitis) should disappear early in the new millennium and a third (measles)should follow shortly after. Conventional vaccines usually depend on one of threedevelopment processes, attenuation of virulent organisms (by passage in cell cultureand(slash)or experimental animals), killing of virulent organisms (by chemical inactivation) or the purification of immunogenic molecules (either proteins or carbohydrates) from wholeorganisms.

These traditional processes, although serendipitous and poorly understood, have produced effectivepharmaceutical products which give excellent protection against diseases such as smallpox, rabies, measles,yellow fever, tetanus and diphtheria. In spite of these successes however, the application of these protocolshave failed to produce safe and efficacious vaccines against other infectious diseases which kill or maim tens ofmillions of people every year. The most important of these are malaria, AIDS, herpes, dengue fever and someforms of viral hepatitis.

Consequently, fundamentally new technologies are required to tackle these important infections. One of themost promising has been the development of genetically modified viruses. This process normally involvestaking a proven safe and efficacious vaccine virus, such as vaccinia or adenovirus, and modifying its genometo include genes coding for immunogenic proteins from other viruses such as HIV or measles. This reviewwill describe the generation of such novel vaccine vectors and compare their advantages and shortcomings. In addition the literature describing their use as experimental vaccines will also be reviewed.

Keywords: Genetically Modified Viruses; Vaccines; Vaccination; Rabies; Poliomyelitis; Measles; Yellow fever; Tetanus; Tetanus; Diphtheria; Smallpox

Language: English

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1389201013378815

Publication date: 2001-03-01

• Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

• In this: publication
• By this: publisher
• In this Subject: Nutrition & Food ,  Biotechnology ,  Pharmacology
• By this author: Stephenson J.R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers